Drug Shortage Report for WELLBUTRIN XL

Last updated on 2018-12-21 History
Report ID 61164
Drug Identification Number 02275104
Brand name WELLBUTRIN XL
Common or Proper name WELLBUTRIN XL
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 90s
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-13
Estimated end date
Actual end date 2018-12-20
Shortage status Resolved
Updated date 2018-12-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2018-12-21 French Compare
v24 2018-12-21 English Compare
v23 2018-12-21 French Compare
v22 2018-12-21 English Compare
v21 2018-12-14 French Compare
v20 2018-12-14 English Compare
v19 2018-11-30 French Compare
v18 2018-11-30 English Compare
v17 2018-11-29 French Compare
v16 2018-11-29 English Compare
v15 2018-11-15 French Compare
v14 2018-11-15 English Compare
v13 2018-11-09 French Compare
v12 2018-11-09 English Compare
v11 2018-10-19 French Compare
v10 2018-10-19 English Compare
v9 2018-10-05 French Compare
v8 2018-10-05 English Compare
v7 2018-09-27 French Compare
v6 2018-09-27 English Compare

Showing 1 to 20 of 25